Lee Fine Chem Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.00 Cr
- Revenue Growth 159.04%
- Profit Growth -76.49%
- Ebitda 25.69%
- Net Worth 23.31%
- Total Assets 39.87%
About Lee Fine Chem
Lee Fine Chem Private Limited (LFCPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2021 (Three years and eight months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹17.00 Cr.
Alla Rani and Venkata Alla serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299TG2021PTC152071
- Company No.
152071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2021
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lee Fine Chem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alla Rani  | Director | 07-Jun-2021 | Current |
| Venkata Alla | Director | 07-Jun-2021 | Current |
Financial Performance of Lee Fine Chem.
Lee Fine Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 159.04% increase. The company also saw a substantial fall in profitability, with a 76.49% decrease in profit. The company's net worth Soared by an impressive increase of 23.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lee Fine Chem?
Unlock access to Lee Fine Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lee Health Domain India Private LimitedAlla Rani is a mutual person
Myosyntho Laboratories Private LimitedAlla Rani and Venkata Alla are mutual person
Charges (Loans)
₹17.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 17.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2023 | Others | ₹17.00 Cr | Open |
How Many Employees Work at Lee Fine Chem?
Lee Fine Chem has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lee Fine Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lee Fine Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.